ORAI1 and pulmonary hypertension: Both ORAI1 and ORAI2 are upregulated in pulmonary arterial smooth muscle cells (PASMCs) under hypoxic conditions and so could prove therapeutic targets for hypoxia-induced pulmonary hypertension [32].